Booth Bruce's Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Jun 25, 2026
- Accession no.
- 0001451612-26-000015
- Filed
- Jun 25, 2026
- Trade date
- Jun 23-25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 30 non-derivative transactions. Open-market sales total $44.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Booth BruceCIK 0001451612 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | SSaleDisposed | −1,235 | $99.98F2 | −$123,475.3 | 3,461,521 | Indirect | |
| Jun 23, 2026 | Common Stock | SSaleDisposed | −173 | $99.98F2 | −$17,296.54 | 613,589 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −103,688 | $100.42F5 | −$10,412,348.96 | 3,357,833 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −14,513 | $100.42F5 | −$1,457,395.46 | 599,076 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −14,490 | $101.14F6 | −$1,465,518.6 | 3,343,343 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −2,029 | $101.14F6 | −$205,213.06 | 597,047 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −9,994 | $107.30F7 | −$1,072,356.2 | 3,333,349 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −159 | $108.02F8 | −$17,175.18 | 3,333,190 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −14,351 | $108.83F9 | −$1,561,819.33 | 3,318,839 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,915 | $110.30F10 | −$211,224.5 | 3,316,924 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −614 | $110.79F11 | −$68,025.06 | 3,316,310 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −719 | $111.89F12 | −$80,448.91 | 3,315,591 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −10,215 | $113.70F13 | −$1,161,445.5 | 3,305,376 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −9,229 | $114.65F14 | −$1,058,104.85 | 3,296,147 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −58,205 | $115.57F15 | −$6,726,751.85 | 3,237,942 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −81,500 | $116.53F16 | −$9,497,195 | 3,156,442 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −24,268 | $117.50F17 | −$2,851,490 | 3,132,174 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −19,089 | $118.60F18 | −$2,263,955.4 | 3,113,085 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,399 | $107.30F7 | −$150,112.7 | 595,648 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −23 | $108.02F8 | −$2,484.46 | 595,625 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −2,011 | $108.83F9 | −$218,857.13 | 593,614 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −265 | $110.30F10 | −$29,229.5 | 593,349 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −86 | $110.79F11 | −$9,527.94 | 593,263 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −100 | $111.89F12 | −$11,189 | 593,163 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,437 | $113.70F13 | −$163,386.9 | 591,726 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −1,289 | $114.65F14 | −$147,783.85 | 590,437 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −8,389 | $115.57F15 | −$969,516.73 | 582,048 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −11,375 | $116.53F16 | −$1,325,528.75 | 570,673 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −3,359 | $117.50F17 | −$394,682.5 | 567,314 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −2,646 | $118.60F18 | −$313,815.6 | 564,668 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.95 to $100.1037 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2) and (5) through (18).
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.95 to $100.9487 inclusive.
Referenced by the price of 2 transactions in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.95 to $101.5246 inclusive.
Referenced by the price of 2 transactions in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.40 to $107.3612 inclusive.
Referenced by the price of 2 transactions in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.4762 to $108.3781 inclusive.
Referenced by the price of 2 transactions in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.5492 to $109.4604 inclusive.
Referenced by the price of 2 transactions in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.66 to $110.57 inclusive.
Referenced by the price of 2 transactions in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.72 to $110.96 inclusive.
Referenced by the price of 2 transactions in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.82 to $111.96 inclusive.
Referenced by the price of 2 transactions in Table I.
- F13
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.0556 to $114.0429 inclusive.
Referenced by the price of 2 transactions in Table I.
- F14
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.0602 to $115.0549 inclusive.
Referenced by the price of 2 transactions in Table I.
- F15
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.0739 to $116.0726 inclusive.
Referenced by the price of 2 transactions in Table I.
- F16
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.0783 to $117.0773 inclusive.
Referenced by the price of 2 transactions in Table I.
- F17
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.0787 to $118.0736 inclusive.
Referenced by the price of 2 transactions in Table I.
- F18
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.0793 to 119.0789 inclusive.
Referenced by the price of 2 transactions in Table I.
Remarks
Due to the 30 line limitation in Table I, this report is being filed across two forms. This is the first of two filings.